IRS Anti-Inversion Rule That Sank Pfizer Deal Struck Down
A Texas federal court on Friday invalidated the anti-inversion rule that sank a planned $160 billion merger between Pfizer Inc. and Irish counterpart Allergan PLC, saying it was unlawfully implemented without...To view the full article, register now.
Already a subscriber? Click here to view full article